PTGER4 and necrotizing enterocolitis: This response to PGE2 was involved in eNOS phosphorylation and nitric oxide (NO) production and was blocked by the EP4 antagonist in vitro, suggesting that targeting the PGE2–EP4–eNOS axis might be a potential clinical and therapeutic strategy for NEC treatment.